# Spirobarbiturates with a pyrrolizidine moiety: synthesis, structure and biological evaluation

**Authors:** Arthur A Puzyrkov, Andrew S Drachuk, Ekaterina A Popova, Alexander V Stepakov, Vitali M Boitsov

PMC · DOI: 10.3762/bjoc.22.20 · Beilstein Journal of Organic Chemistry · 2026-02-17

## TL;DR

This paper describes the synthesis and testing of new spirobarbiturate compounds with potential anti-cancer properties.

## Contribution

A novel one-pot method for synthesizing polycyclic spirobarbiturates with a pyrrolizidine moiety is introduced.

## Key findings

- The reaction stereoselectivity depends on the substituents in the maleimide.
- X-ray diffraction confirmed the configuration of stereocenters in two adducts.
- Some compounds showed antiproliferative effects against cancer cell lines.

## Abstract

Polycyclic spirobarbiturates containing a pyrrolizidine moiety were synthesized via a one-pot three-component 1,3-dipolar cycloaddition reaction of alloxan, ʟ-proline and N-substituted maleimides. The reaction stereoselectivity was found to depend on the nature of substituents in the maleimide: in most cases the endo-isomer is the main (or only) product, but for some N-arylmaleimides the exo-product is predominant. The proposed mechanism is discussed, and the products were characterized by detailed spectral analysis. The configuration of the stereocenters was determined by X-ray diffraction analysis (XRD) for two adducts, followed by Hirshfeld surface analysis. The antiproliferative effect of the synthesized compounds against cancer cell lines was assessed.

## Linked entities

- **Chemicals:** alloxan (PubChem CID 5781), L-proline (PubChem CID 145742)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** ACHE (acetylcholinesterase (Yt blood group)) [NCBI Gene 43] {aka ACEE, ARACHE, N-ACHE, YT}, OGA (O-GlcNAcase) [NCBI Gene 10724] {aka MEA5, MGEA5, NCOAT}, KCNH2 (potassium voltage-gated channel subfamily H member 2) [NCBI Gene 3757] {aka ERG-1, ERG1, H-ERG, HERG, HERG1, Kv11.1}, CYP2D6 (cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)) [NCBI Gene 1565] {aka CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2}
- **Diseases:** toxicity (MESH:D064420), Cancer (MESH:D009369), melanoma (MESH:D008545), inflammatory (MESH:D007249), cervical carcinoma (MESH:D002583), neurological disorders (MESH:D009461), cardiotoxicity (MESH:D066126), erythroleukemia (MESH:D004915)
- **Chemicals:** alpha-amino acid (MESH:D000596), N-(2-methoxyphenyl)maleimide (MESH:C068748), pipecolic acid (MESH:C031345), chlorine (MESH:D002713), cyclopropane (MESH:C030797), alloxan (MESH:D000496), pyrrolidine (MESH:C032519), deltaF (MESH:D011239), 1,4-dioxane (MESH:C025223), 1H (-), Barbituric acid (MESH:C032232), tetrahydroquinoline (MESH:C542964), imine (MESH:D007097), N-methylmaleimide (MESH:C527323), megalanthonine (MESH:C117182), cyclopropene (MESH:C021985), Trp (MESH:D014364), H (MESH:D006859), Lys (MESH:D008239), thiazolidinecarboxylic acid (MESH:C003438), halogens (MESH:D006219), murexide (MESH:D009114), Bn (MESH:C072598), barbiturates (MESH:D001463), maleimide (MESH:C043592), indolin-2-one (MESH:C456900), cyclopentane (MESH:D003517), lactone (MESH:D007783), CH4 (MESH:D008697), succinimide (MESH:C032620), N (MESH:D009584), CH2Cl2 (MESH:D008752), NO2 (MESH:D009585), C (MESH:D002244), Maleimides (MESH:D008301), acetonitrile (MESH:C032159), L-proline (MESH:D011392), pyrrolizidine alkaloids (MESH:D011763), tryptanthrin (MESH:C046243), chalcone (MESH:D002599), O (MESH:D010100), -p (MESH:D010758), alkaloids (MESH:D000470), tetracyanoethylene (MESH:C003393), dimethyl acetylenedicarboxylate (MESH:C022918), 13C (MESH:C000615229), benzyl chlorides (MESH:C021292), barbital (MESH:D001462), azetidine-2-carboxylic acid (MESH:D001383), zoliflodacin (MESH:C000599190), cyclic amino acids (MESH:D000598), cyclohexane (MESH:C506365), DBU (MESH:C031033), fluorine (MESH:D005461), octanol (MESH:D000442), pochonicine (MESH:C546440), amide (MESH:D000577), water (MESH:D014867), Mo(CO)6 (MESH:C434645), echimidine (MESH:C000615871)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025), 8DNH — Xenopus laevis (African clawed frog), Spontaneously immortalized cell line (CVCL_4564), HeLa — Homo sapiens (Human), Human papillomavirus-related cervical squamous cell carcinoma, Cancer cell line (CVCL_T292), Sk-mel-2 — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_0550), K562 — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_0004)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12927484/full.md

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12927484/full.md

## References

67 references — full list in the complete paper: https://tomesphere.com/paper/PMC12927484/full.md

---
Source: https://tomesphere.com/paper/PMC12927484